N. E. Nathanson

Q: What Schools Are Affiliated With N. E. Nathanson

N. E. Nathanson is affiliated with the following schools: Johns Hopkins University, University of Pennsylvania

N. E. Nathanson's AcademicInfluence.com Rankings

N. E. Nathanson

Philosophy

#7533

World Rank

#10759

Historical Rank

Logic

#4584

World Rank

#5895

Historical Rank

philosophy Degrees

N. E. Nathanson

Biology

#10202

World Rank

#13509

Historical Rank

Virology

#238

World Rank

#245

Historical Rank

Immunology

#635

World Rank

#656

Historical Rank

Molecular Biology

#1459

World Rank

#1486

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

N. E. Nathanson's Degrees

PhD Molecular Biology Stanford University
Doctorate Medicine Harvard University

Why Is N. E. Nathanson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

N. E. Nathanson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1 (1992) (384)
From Emergence to Eradication: The Epidemiology of Poliomyelitis Deconstructed (2010) (334)
Human exposure to SV40: review and comment. (1976) (314)
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. (1993) (249)
An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. (1984) (228)
Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types (1989) (223)
Circulating vaccine-derived polioviruses: current state of knowledge. (2004) (219)
The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. (1979) (215)
Requirement for Θ-Bearing Cells in Lymphocytic Choriomeningitis Virus-induced Central Nervous System Disease (1972) (190)
Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. (1976) (188)
THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. II. RELATIONSHIP OF POLIOMYELITIS TO CUTTER VACCINE. (1995) (185)
Seasonality and the requirements for perpetuation and eradication of viruses in populations. (1979) (180)
IMMUNOPATHOGENESIS OF ACUTE CENTRAL NERVOUS SYSTEM DISEASE PRODUCED BY LYMPHOCYTIC CHORIOMENINGITIS VIRUS (1972) (136)
A Sound Rationale Needed for Phase III HIV-1 Vaccine Trials (2004) (133)
Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. (1976) (121)
The genetics of susceptibility to multiple sclerosis. (1982) (116)
Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. (1974) (111)
Bovine spongiform encephalopathy (BSE): causes and consequences of a common source epidemic. (1997) (111)
THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. I. BACKGROUND. (1963) (110)
Immunosuppression And Experimental Virus Infection Of The Nervous System* (1970) (110)
Acute rabies death mediated by antibody (1981) (107)
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor (1990) (106)
IMMUNOPATHOGENESIS OF ACUTE CENTRAL NERVOUS SYSTEM DISEASE PRODUCED BY LYMPHOCYTIC CHORIOMENINGITIS VIRUS (1972) (104)
Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. (1983) (94)
Eastern equine encephalitis. Distribution of central nervous system lesions in man and Rhesus monkey. (1969) (93)
Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. (1982) (89)
Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. (1982) (88)
Organization of the middle RNA segment of snowshoe hare Bunyavirus. (1988) (72)
The pathogenesis of poliomyelitis: what we don't know. (2008) (71)
Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. (1984) (70)
Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. (1971) (70)
Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. (1994) (70)
The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. (1978) (69)
Experimental encephalitis following peripheral inoculation of West Nile virus in mice of different ages (1970) (68)
Poliomyelitis Eradication--a Dangerous Endgame (2002) (63)
A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus. (1987) (62)
Cerebellar Hypoplasia in Neonatal Rats Caused by Lymphocytic Choriomeningitis Virus (1971) (62)
An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function (1985) (61)
Virulence of La Crosse virus is under polygenic control (1986) (61)
Eradication of poliomyelitis in the United States. (1982) (60)
Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. (1972) (59)
The emergence of new virus diseases: an overview (1994) (59)
Experimental visna in Icelandic sheep: the prototype lentiviral infection. (1985) (58)
La Crosse bunyavirus can mediate pH-dependent fusion from without. (1984) (58)
The role of nonhuman primates in the development of an AIDS vaccine. (1999) (56)
Viral Pathogenesis and Immunity (2001) (56)
Potentiation of Experimental Arbovirus Encephalitis by Immunosuppressive Doses of Cyclophosphamide (1968) (55)
Pathogenesis of West Nile Virus encepahlitis in mice and rats. II. Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain. (1967) (54)
The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein. (1989) (54)
Pathogenesis of West Nile Virus encephalitis in mice and rats. 1. Influence of age and species on mortality and infection. (1967) (54)
Emerging Viral Diseases (2016) (53)
California Serogroup Viruses (1989) (53)
The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. 1963. (1995) (52)
Biological considerations in the development of a human immunodeficiency virus vaccine. (2000) (52)
Immunosuppression: a means to assess the role of the immune response in acute virus infections. (1971) (49)
Epidemiology of multiple sclerosis: critique of the evidence for a viral etiology. (1978) (49)
Infectious Disease Epidemiology. (1996) (48)
The effect of post-infection immunization on the severity of experimental visna. (1981) (48)
Histological studies of the monkey neurovirulence of group B arboviruses. I. A semiquantitative grading scale. (1965) (45)
Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies (1995) (45)
Fatal Japanese encephalitis virus infection in immunosuppresed spider monkeys. (1970) (43)
Tropism of bunyaviruses: evidence for a G1 glycoprotein-mediated entry pathway common to the California serogroup. (1995) (43)
Completion of the La Crosse virus genome sequence and genetic comparisons of the L proteins of the Bunyaviridae. (1995) (42)
Heterotopic cerebellar granule cells following administration of cyclophosphamide to suckling rats. (1969) (40)
Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment (1991) (38)
Lymphocytic choriomeningitis. Pathogenesis. (1974) (38)
Genetic determinants of virus susceptibility: epidemiologic implications of murine models. (1981) (37)
Pathogenesis of visna. III. Immune responses to central nervous system antigens in experimental allergic encephalomyelitis and visna. (1976) (37)
Experimental poliomyelitis following intramuscular virus injection. III. The effect of passive antibody on paralysis and viremia. (1962) (36)
Reassortment of La Crosse and Tahyna bunyaviruses in Aedes triseriatus mosquitoes. (1991) (36)
Surveillance of poliomyelitis in the United States in 1955. (1956) (36)
THE CUTTER INCIDENT POLIOMYELITIS FOLLOWING FORMALDEHYDE-INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955III. COMPARISON OF THE CLINICAL CHARACTER OF VACCINATED AND CONTACT CASES OCCURRING AFTER USE OF HIGH RATE LOTS OF CUTTER VACCINE (1963) (35)
The pathology of visna and maedi in sheep. (1976) (35)
Experimental poliomyelitis following intramuscular virus injection. I. The effect of neural block on a neurotropic and a pantropic strain. (1961) (35)
MULTIPLE SCLEROSIS AND CANINE DISTEMPER IN ICELAND (1978) (35)
Viral Hemorrhagic Encephalopathy of Rats (1967) (34)
Viral hemorrhagic encephalopathy of rats. II. Pathogenesis of central nervous system lesions. (1970) (34)
Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses. (1993) (33)
Genetic determinants of the virulence and infectivity of La Crosse virus. (1988) (32)
Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. (1993) (32)
Pathogenesis of Cerebellar Hypoplasia Produced by Lymphocytic Choriomeningitis Virus Infection of Neonatal Rats: Protective Effect of Immunosuppression with Anti-Lymphoid Serum (1974) (31)
The cutter incident (1995) (31)
Replication of a macrophage-tropic strain of human immunodeficiency virus type 1 (HIV-1) in a hybrid cell line, CEMx174, suggests that cellular accessory molecules are required for HIV-1 entry (1993) (29)
Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers. (1966) (29)
VIRUS-INDUCED CELL-MEDIATED IMMUNOPATHOLOGICAL DISEASE (1975) (28)
Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis (2017) (28)
Historical roots (1967) (28)
Modifications by sodium auro-thio-malate of the expression of virulence in mice by defined strains of Semliki Forest virus. (1974) (27)
Pathogenesis of Viral Infections (2010) (27)
The evolution of virus diseases: their emergence, epidemicity, and control. (1993) (26)
Polygenic control of neuroinvasiveness in California serogroup bunyaviruses (1993) (26)
Pathogenesis of visna. IV. Spinal fluid studies. (1979) (25)
Histological studies of the monkey neurovirulence of group B arboviruses. 3. Relative virulence of selected viruses. (1967) (25)
Retroviruses and the Nervous System (1995) (25)
Recovery from experimental rabies by adoptive transfer of immune cells. (1981) (24)
Parvovirus hemorrhagic encephalopathy of rats. Electron microscopic observations of the vascular lesions. (1972) (24)
Host Genes that Influence Susceptibility to Viral Diseases (1984) (24)
Pathogenesis of LCM Disease in the Rat (1973) (23)
Tacaribe virus infection of the mouse: an immunopathologic disease model. (1974) (23)
Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site. (1985) (23)
Epidemiologic aspects of poliomyelitis eradication. (1984) (23)
Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1: Report* from a meeting of the WHO-UNAIDS Vaccine Advisory Committee** Geneva, 21–23 February 2000 (2001) (22)
Experimental visna in foetal Icelandic sheep. (1978) (22)
Enteric transmission of parvoviruses: pathogenesis of rat virus infection in adult rats. (1972) (22)
Precipitating antibodies in experimental visna and natural progressive pneumonia of sheep. (1985) (21)
Sero-epidemiological study of rat virus infection in a closed laboratory colony. (1971) (20)
Histological studies of the monkey neurovirulence of group B arboviruses. IV. Evaluation of an attenuated strain (E5) of Langat virus. (1968) (20)
Pathogenesis of HIV Encephalopathy a (1994) (19)
EXPERIMENTAL INFECTION OF MONKEYS WITH LANGAT VIRUS I. COMPARISON OF VIREMIA FOLLOWING PERIPHERAL INOCULATION OF LANGATJ (1966) (18)
Visna. The Biology of the Agent and the Disease (1979) (18)
David Bodian's contribution to the development of poliovirus vaccine. (2005) (18)
Inhibitory effects of passive antibody on virulent poliovirus excretion and on immune response in chimpanzees. (1960) (18)
Pathogenesis of type 1 dengue virus infection in suckling, weaning and adult mice. II. Immunofluorescent and histological studies. (1973) (17)
Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964-1988. (1992) (17)
Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones (1990) (16)
Pathogenesis of Diseases Caused by Viruses of the Bunyavirus Genus (1996) (15)
Immunopathogenesis of visna. A slow virus disease of the central nervous system. (1978) (15)
Requirement for theta-bearing lymphocytes in lymphocytic chorio- meningitis (lcm) virus induced central nervous system (cns) disease. Abstr. (1972) (15)
Experimental poliomyelitis following intramuscular virus injection. II. Viremia and the effect of antibody. (1961) (15)
Cerebrospinal fluid immunoglobulins in sheep with visna, a slow virus infection of the central nervous system (1982) (14)
Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. II. An ultrastructural study of the immune-mediated pathology. (1975) (14)
Use of poliomyelitis vaccine under epidemic conditions; report of outbreak of poliomyelitis among naval personnel and dependents in Hawaii. (1956) (14)
Genetics, infectivity and virulence of California serogroup viruses. (1992) (14)
Effect of Antilymphocyte Serium on Tacaribe Virus Infection in Infant Mice (1971) (13)
Detection of viral genes and their products in chronic neurological diseases (1984) (13)
Epidemic poliomyelitis during 1956 in Chicago and Cook County, Illinois (1959) (13)
Virus-specific immunologic depression in mice following combined immunization and cyclophosphamide-induced immunosuppression. (1971) (13)
Replication in cultured C2C12 muscle cells correlates with the neuroinvasiveness of California serogroup bunyaviruses. (1994) (13)
Virus perpetuation in populations: biological variables that determine persistence or eradication (2005) (12)
The age distribution of poliomyelitis in the United States in 1955. (1957) (12)
Immunofluorescent studies of the replication of rat virus (HER strain) in tissue culture. (1969) (12)
Viral hemorrhagic encephalopathy of rats. I. Isolation, identification, and properties of the HER strains of rat virus. (1970) (12)
Monoclonal antibodies against the G1 and nucleocapsid proteins of LaCrosse and Tahyna viruses. (1983) (12)
Experimental infection of monkeys with Langat virus II. Turnover of circulating virus (2000) (11)
Experimental infection of monkeys with Langat virus. II. Turnover of circulating virus. (1967) (11)
Surveilance of poliomyelitis in the United States in 1956. (1957) (11)
Primary demyelination in visna (1982) (11)
HIV-1 pseudotype virus containing a Cocal virus genome and an HIV envelope: construction, assay and use. (1993) (11)
LYMPHOCYTIC CHORIOMENINGITIS VIRUS‐INDUCED CEREBELLAR HYPOPLASIA IN NEONATAL RATS * (1971) (9)
Viral pathogenesis : from basics to systems biology (2016) (9)
Towards an AIDS vaccine: The role of nonhuman primates (1999) (9)
The ultrastructure of early visna lesions (1977) (8)
Virology. Poliomyelitis eradication--a dangerous endgame. (2002) (8)
Slow viruses and chronic disease: the contribution of epidemiology. (1980) (8)
Introduction: Molecular epidemiology of viruses (1995) (7)
Pathogenesis of visna: review and speculation. (1976) (7)
Emergence of new viral infections: implications for the blood supply. (1998) (7)
MULTIPLE SCLEROSIS, CANINE DISTEMPER, AND MEASLES IMMUNISATION (1978) (7)
Harnessing research to control AIDS (1998) (6)
An unusual x-ray finding in tuberous sclerosis. (1966) (6)
Bunyaviridae: Pathogenesis. (1991) (6)
Fatal central nervous system (cns) disease in lymphocytic chorio- meningitis (lcm) virus carrier mice given lcm-immune donor spleen cells. Abstr. (1971) (6)
Directions for future research on the pathogenesis of arenaviral infections. (1975) (5)
Introduction: New and emerging virus diseases (1994) (5)
An ultrastructural study of the cerebrospinal fluid in visna (1979) (5)
Human immunodeficiency virus: an agent that defies vaccination. (1989) (5)
Chapter 1 The Human Toll of Viral Diseases Past Plagues and Pending Pandemics (2016) (5)
Poliovirus vaccines: past, present, and future. (2011) (5)
Eradication of poliovirus: fighting fire with fire. (2011) (5)
Antiviral Therapy (2016) (5)
Chapter 16 Emerging Viral Diseases Why We Need to Worry about Bats, Camels, and Airplanes (2016) (4)
THE ENTERPRISE FUNDS IN EUROPE AND EURASIA : Successes and Lessons Learned (2013) (4)
Experimental infections of monkeys with Langat virus. I. Comparison of viremia following peripheral inoculation of Langat and Japanese encephalitis viruses. (1966) (4)
Towards an AIDS vaccine: the role of primate models. (1998) (3)
Cyclophosphamide-induced protection against acute lymphocytic choriomeningitis in mice. (1971) (3)
PATHOGENESIS OF VISINA. I. SEQUENTIAL VIROLOGICAL, IMMUNOLOGICAL, AND PATHOLOGICAL OBSERVATIONS: 75 (1976) (3)
Tamiami Virus-Induced Immunopathological Disease of the Central Nervous System (1973) (3)
HIV/AIDS epidemic: The whole truth. (2016) (3)
The surveillance of poliomyelitis in the United States in 1955. (1956) (3)
BUNYAVIRIDAE | General Features (1999) (3)
VIRAL ETIOLOGY OF MULTIPLE SCLEROSIS: A CRITIQUE OF THE EVIDENCE (1985) (3)
STUDIES ON THE IMMUNOLOGIC CLEARANCE OF EXPERIMENTAL RABIES IN MICE: 82 (1977) (2)
Mechanisms of Bunyavirus Virulence: A Genetic Approach. (1984) (2)
[Hemorrhagic encephalopathy induced by cyclophosphamide (NSC-26271) in suckling rats]. (1970) (2)
FAILURE TO DEMONSTRATE DORSAL ROOT SPROUTING USING THE PROTARGOL SILVER STAIN FOLLOWING SPINAL CORD HEMISECTION OR HEMISPHERECTOMY IN THE CAT. (1965) (2)
Development of an AIDS vaccine: A daunting epidemiological challenge (2004) (1)
Patterns of Infection (2016) (1)
Molecular Approaches to the Study of Bunyavirus Encephalitis (1992) (1)
Organization of the middle RNA segment of snowshoe hare virus (1988) (1)
Replication ofa Macrophage-Tropic Strain ofHuman Immunodeficiency VirusType1(HIV-1)ina HybridCellLine, CEMx174,Suggests thatCellular Accessory Molecules Are Required forHIV-1Entry (1993) (1)
IMMUNOSUPPRESSION AND VIRUS INFECTION OF RODENTS1 (2012) (1)
Confronting the HIV pandemic [editorial] (1999) (1)
Book Review:Neurologic Examination of the Dog with Clinicopathologic Observations. John T. McGrath (1959) (1)
Immunology of Rabies, Arbovirus Encephalitis, Parainfectious Encephalitis, and Guillain-Barré Syndrome (1982) (1)
The Human Toll of Viral Diseases (2016) (1)
12 Korean hemorrhagic fever and hantavirus pulmonary syndrome: Examples of emerging hantaviral diseases (1998) (1)
Chapter 7 Patterns of Infection Unwanted Guests—Quick Visits and Extended Stays (2016) (1)
Circulating vaccine-derived polioviruses: current state of (2004) (1)
Immune Response to Rabies Virus (2017) (0)
Special report on cases of poliomyelitis among unvaccinated persons having familial contact with individuals who have received poliomyelitis vaccine (1955) (0)
Invited Commentary on “Poliomyelitis Infection in Households: Frequency of Viremia and Specific Antibody Response” (1995) (0)
A Summary of data on cases of poliomyelitis occurring in association with Cutter vaccine (1955) (0)
Molecular determinants of the virulence of California serogroup bunyaviruses (1993) (0)
Letter from Neal Nathanson to Aaron J. Shatkin (1974) (0)
Microbicides 2000 conference. Welcoming remarks. The role of the Office of AIDS Research, NIH, USA. (2001) (0)
11 Bovine Spongiform Encephalopathy and Related Diseases (1999) (0)
Experimental infection of monkeys with Langat virus. 3. Infection produced by virus feeding. (1969) (0)
Pathogenic characteristics of a neuroattenuated bunyavirus variant (1988) (0)
Priorities for the Use of Hepatitis B Vaccine (1984) (0)
Mechanisms of Oncogenesis MECHANISMS OF ONCOGENESIS Tumor suppressor genes (2007) (0)
An estimate of the extent of the national problem associated with Cutter vaccine (1955) (0)
NEUROLOGICAL ILLNESS FOLLOWING POLIOMYELITIS VACCINATION (1956) (0)
Comparative Pathology in Monkeys. B. A. Lapin and L. A. Yakovleva. Translated from the Russian by the U.S. Joint Publications Research Service. Thomas, Springfield, III., 1963. xvi + 272 pp. Illus. $10 (1963) (0)
Immunologic clearance of experimental rabies virus infection in mice. Abstr. (1978) (0)
Book Review:Functional Neuro-Anatomy, Including an Atlas of the Brain Stem. A. R. Buchanan (1959) (0)
Alternative Receptors for HIV-1 in Nervous System Tissues (1995) (0)
RABIES POST-EXPOSURE IMMUNOPROPHYLAXIS IS SAFE AND EFFECTIVE (1981) (0)
Strains ofHumanImmunodeficiency Virus Type1Utilize theCD4Receptor (1990) (0)
Escape from immune surveillance during persistent virus infection. (1983) (0)
Neuroattenuation ofan Avirulent Bunyavirus Variant Maps totheL RNA Segment (1991) (0)
Emerging infectious diseases (2003) (0)
Special Theme – Polio Eradication : End-Stage Challenges Circulating vaccine-derived polioviruses (2018) (0)
SUSTAINING THE INVESTMENT IN AIDS RESEARCH (1999) (0)
The A.R.M. Decision (1965) (0)
Isolation of a virus which produces acute hemorrhagic encephalopathy in suckling rats. (1968) (0)
Breakthrough: Nobel Prize Discoveries in Viral Pathogenesis (2016) (0)
Role of the Gl glycoprotein of La Crosse virus in pH dependent fusion (1985) (0)
Science and Engineering Programs at The University of Pennsylvania (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With N. E. Nathanson?

N. E. Nathanson is affiliated with the following schools:

N. E. Nathanson's Academic­Influence.com Rankings

N. E. Nathanson's Degrees

Why Is N. E. Nathanson Influential?

N. E. Nathanson's Published Works

Published Works

What Schools Are Affiliated With N. E. Nathanson?

N. E. Nathanson's AcademicInfluence.com Rankings